Jeffrey S. Hatfield
@jeffreyshatfield
Director
Building aTYR PHARMA INC as Director
- Website not added yet
- LinkedIn not added yet
- X not added yet
- Instagram not added yet
- Facebook not added yet
Founder Rating
1500
Everyone starts at 1500.
It only moves when two founders agree to a duel.
Named alongside
- Akkaraju C. SrinivasDirector
- Amir C. NashatDirector
- Amir H. Nashat, Sc.D.Director
- David C. WeinerExecutive Officer
- Ed C. PenhoetDirector
- Frederic C. ChereauExecutive Officer
- James C. BlairDirector
- John D. MendleinExecutive Officer, Director
- Adam S. LevyExecutive Officer
- Arlene M. MorrisDirector
- Bruce L BoothDirector
- Christopher D. BowdenDirector
- Christopher L. BowdenDirector
- Diana A. EscolarExecutive Officer
- Jason A. LeveroneExecutive Officer
- Joesph L. TurnerDirector
Contribution
Jeffrey's ideas, decisions and failures appear here once this profile is claimed.
Companies
- aTYR PHARMA INCBiological Products, (No Diagnostic Substances); listed on Nasdaq as ATYR; filing with the SEC since 2005Director · Biotechnology · SAN DIEGO, United States
- MIRAGEN THERAPEUTICS, INC.Pharmaceutical Preparations; formerly MIRAGEN THERAPEUTICS, INC.; listed on Nasdaq as VRDN; filing with the SEC since 2013Director · Biotechnology · BOULDER, United States